| Vancomycin in peritoneal dialysis: clinical pharmacology considerations in therapy E Lam, YT Lien, WK Kraft, B Piraino, V Vozmediano, S Schmidt, J Zhang Peritoneal Dialysis International 40 (4), 384-393, 2020 | 23 | 2020 |
| Unnecessary tests and procedures in patients presenting with solid tumors of the pancreas M Cooper, NA Newman, AM Ibrahim, E Lam, JM Herman, VK Singh, ... Journal of Gastrointestinal Surgery 17 (7), 1218-1223, 2013 | 18 | 2013 |
| Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy E Lam, B Bashir, M Chaballa, WK Kraft Expert review of clinical pharmacology 12 (8), 781-790, 2019 | 17 | 2019 |
| Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): a prospective cohort study with intensive monitoring FTT Lai, MTY Leung, EWW Chan, L Huang, LKW Lau, K Peng, ... Vaccine 40 (10), 1390-1396, 2022 | 16 | 2022 |
| Accuracy of marketing claims by providers of stereotactic radiation therapy AK Narang, E Lam, MA Makary, TL DeWeese, TM Pawlik, PJ Pronovost, ... Journal of oncology practice 9 (1), 57-62, 2013 | 15 | 2013 |
| Pharmacokinetics of ketamine at dissociative doses in an adult patient with refractory status asthmaticus receiving extracorporeal membrane oxygenation therapy E Lam, A Rochani, G Kaushal, BN Thoma, J Tanjuakio, FM West, ... Clinical therapeutics 41 (5), 994-999, 2019 | 14 | 2019 |
| Simultaneous quantitative LC–MS method of ketamine, midazolam and their metabolites (dehydronorketamine, norketamine and 1hydroxymidazolam) for its application in patients on … A Rochani, E Lam, J Tanjuakio, H Hirose, WK Kraft, G Kaushal Journal of pharmaceutical and biomedical analysis 178, 112947, 2020 | 9 | 2020 |
| Twice‐Daily Doravirine Overcomes the Interaction Effect from Once‐Weekly Rifapentine and Isoniazid in Healthy Volunteers E Lam, J Schaefer, R Zheng, T Zhan, WK Kraft Clinical and translational science 13 (6), 1244-1250, 2020 | 5 | 2020 |
| Population pharmacokinetic and safety analysis of ropivacaine used for erector spinae plane blocks ES Schwenk, E Lam, AA Abulfathi, S Schmidt, A Gebhart, SD Witzeling, ... Regional Anesthesia & Pain Medicine 48 (9), 454-461, 2023 | 4 | 2023 |
| Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis E Lam, Y Ting (Kayla) Lien, WK Kraft, DF Stickle, B Piraino, J Zhang Clinical and Translational Science 15 (3), 649-657, 2022 | 3 | 2022 |
| Partnering with clinical pharmacologists to improve medication use in children SJ Miyagi, E Lam, ST Girdwood The Journal of pediatrics 227, 5-8, 2020 | 3 | 2020 |
| Apixaban Discontinuation for Invasive Or major Surgical procedures (ADIOS): A prospective cohort study GJ Merli, WK Kraft, LH Eraso, T Galanis, LJ Thomson, GO Ouma, ... Vascular Medicine 27 (3), 269-276, 2022 | 2 | 2022 |
| Longitudinal evaluation of azithromycin and cytokine concentrations in amniotic fluid following one‐time oral dosing in pregnancy RC Boelig, E Lam, A Rochani, G Kaushal, A Roman, WK Kraft Clinical and Translational Science 14 (6), 2431-2439, 2021 | 2 | 2021 |
| Bidirectional pharmacokinetics of doravirine, tenofovir, and feminizing hormones in transgender women (IDentify): A randomized crossover trial K Lam, WK Kraft, T Zhan, E Lam Clinical and Translational Science 17 (3), e13721, 2024 | | 2024 |
| 503 Fetal and neonatal drug exposure following nipocalimab treatment in pregnant women at risk of EOS-HDFN E Lam, JH Leu, J Zhou, Y Xiong, L Ling, K Cofsky, U Amin, W Sirah, ... American Journal of Obstetrics & Gynecology 230 (1), S274-S275, 2024 | | 2024 |
| 232 Nipocalimab pharmacokinetic/pharmacodynamic and exposure-response modeling in pregnancies at risk for early-onset severe (EOS) HDFN J Zhou, JH Leu, Y Xiong, E Lam, L Ling, U Amin, W Sirah, ... American Journal of Obstetrics & Gynecology 230 (1), S138, 2024 | | 2024 |
| 2548. Pharmacokinetic Analysis of Co-Administering Doravirine, Tenofovir Disoproxil Fumarate, Estradiol, and Spironolactone K Lam, T Zhan, W Kraft, E Lam Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2165, 2023 | | 2023 |
| Open-label Phase 3 Study of Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Pharmacokinetics, Effectiveness, Safety, and Immunogenicity over … N Ruperto, DJ Lovell, S Ringold, XL Xu, JH Leu, E Lam, Y Wang, ... ARTHRITIS & RHEUMATOLOGY 75, 695-696, 2023 | | 2023 |
| OC07. 03: Nipocalimab pharmacodynamics in a phase 2 study in pregnancies at risk of early‐onset severe hemolytic disease of the fetus and newborn LE Ling, JH Leu, A Mirza, E Lam, M de Haas, M Tjoa, S Saeed‐Khawaja, ... Ultrasound in Obstetrics & Gynecology 62, 15-16, 2023 | | 2023 |
| Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy (PAP-UP) R Zheng, E Lam, P Altshuler, M Crutcher, H Lavu, CJ Yeo, D Stickle, ... | | 2023 |
